Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Baxter
Medtronic
Mallinckrodt
Johnson and Johnson

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Ombrabulin

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Ombrabulin?

Ombrabulin is an investigational drug.

There have been 11 clinical trials for Ombrabulin. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2008.

The most common disease conditions in clinical trials are Neoplasms, Sarcoma, and Ovarian Neoplasms. The leading clinical trial sponsors are Sanofi and [disabled in preview].

Recent Clinical Trials for Ombrabulin
TitleSponsorPhase
Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/PaclitaxelSanofiPhase 2
Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung CancerSanofiPhase 2
A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid TumorsSanofiPhase 1

See all Ombrabulin clinical trials

Clinical Trial Summary for Ombrabulin

Top disease conditions for Ombrabulin
Top clinical trial sponsors for Ombrabulin

See all Ombrabulin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Colorcon
Dow
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.